Osr Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-12-2024
- Paid Up Capital ₹ 0.10 M
as on 16-12-2024
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -61.21%
(FY 2022)
- Profit -100.42%
(FY 2022)
- Ebitda -257.02%
(FY 2022)
- Net Worth -0.00%
(FY 2022)
- Total Assets 4.36%
(FY 2022)
About Osr Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Omkar Abhyankar and Abhishek Jawahirani serve as directors at the Company.
- CIN/LLPIN
U51101MH2012PTC228379
- Company No.
228379
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Mar 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Osr Healthcare Private Limited offer?
Osr Healthcare Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Common Disease Medicines, Steroid, Immunization & Vaccination Drugs, Vaccines, Antiviral Drugs, Pain Relief Drugs & Pharmaceuticals, Osteoporosis Medications, Sexual Wellness Products.
Who are the key members and board of directors at Osr Healthcare?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Omkar Abhyankar | Director | 17-Mar-2012 | Current |
Abhishek Jawahirani | Director | 30-Sep-2016 | Current |
Financial Performance of Osr Healthcare.
Osr Healthcare Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 61.21% decrease. The company also saw a substantial fall in profitability, with a 100.42% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Osr Healthcare?
In 2021, Osr Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Cloverleaf Ecom Private LimitedActive 9 years 5 months
Omkar Abhyankar and Abhishek Jawahirani are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Osr Healthcare?
Unlock and access historical data on people associated with Osr Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Osr Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Osr Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.